Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 7 October

Jessica Amir
October 7, 2021

Morning Bell 6 October

Jessica Amir
October 6, 2021

Morning Bell 5 October

Jessica Amir
October 5, 2021

Morning Bell 4 October

Sophia Mavridis
October 4, 2021

Weekly Wrap 1 October

Jessica Amir
October 1, 2021

Morning Bell 1 October

Sophia Mavridis
October 1, 2021

Morning Bell 30 September

Paulina Peters
September 30, 2021

Morning Bell 29 September

Jessica Amir
September 29, 2021

Morning Bell 28 September

Jessica Amir
September 28, 2021

Morning Bell 27 September

Jessica Amir
September 27, 2021

Weekly Wrap 24 September

Jessica Amir
September 24, 2021